stock-detail (TKAI)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Understanding How Cancer Spreads, and How It May Be Stopped

4/11/2016 11:01 am

(Medscape Medical News) Apr 8, 2016 - The latest findings on how cancer cells metastasize from primary to distant sites are highlighted in a special issue of Science, published on April 8.

A Zika Breakthrough: Scientists Detail How Virus Can Attack Fetal Brain

3/4/2016 12:03 pm

(Washington Post/To Your Health) Mar 4, 2016 - A team of U.S. researchers announced Friday that they believe they have discovered a mechanism for how the Zika virus can cause the rare birth defect known as microcephaly, in which babies are born with abnormally small heads and underdeveloped brains.

Study Finds Significant Cognitive Impairment In Adult Survivors Of Childhood Brain Tumors

2/2/2016 12:00 pm

(St. Jude) Feb 1, 2016 - The most comprehensive study of its kind concluded that decades after treatment, brain cancer survivors show deficits in cognition, education and employment.

'Cancer Vaccine' Startup Gritstone Ascends With $100M Round

10/20/2015 11:05 am

(San Francisco Business Times) Oct 20, 2015 - An East Bay biotech startup will use a $102 million venture capital investment to anchor its climb toward cancer's latest, greatest summit.

Japan Acknowledges Possible Radiation Casualty At Fukushima Nuclear Plant

10/20/2015 11:05 am

(Reuters) Oct 20, 2015 - Japan on Tuesday acknowledged the first possible casualty from radiation at the wrecked Fukushima nuclear power plant, a worker who was diagnosed with cancer after the crisis broke out in 2011.

Roswell Park Acquires Niagara Falls Oncology Practice

10/20/2015 11:05 am

(Buffalo News) Oct 19, 2015 - Roswell Park Cancer Institute has acquired Cancer Care & Hematology of Niagara, the Niagara Falls-based oncology practice of Dr. Mohamed S. Ahmed.

Lancet Oncology Commission Calls for Expanding Global Access to Radiotherapy

10/20/2015 11:03 am

(MarketWatch) Oct 20, 2015 - Increasing access to radiotherapy worldwide through greater investment could save millions of lives, according to The Lancet Oncology Commission's report presented yesterday at the 2015 annual meeting of the American Society for Radiation Oncology (ASTRO).

Susan G. Komen®: Women Should Have Access to, Coverage for, Mammography

10/20/2015 11:03 am

(Susan G. Komen®) Oct 20, 2015 - The Susan G. Komen® breast cancer organization today said that all women should have access to regular mammograms when they and their health care providers decide that it is the right time for screening based on individual risk for breast cancer, and that the screening tests should be covered by third-party payers such as insurance companies and government programs.

Kite Pharma Announces Exclusive License with the National Institutes of Health for T Cell Receptor (TCR)-Based Products to Treat Tumors Expressing MAGE

10/20/2015 11:03 am

(Kite) Oct 20, 2015 - Kite Pharma, Inc. today announced that the Company has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) for intellectual property related to T Cell Receptor (TCR)-based product candidates directed against MAGE A3 and A3/A6 antigens for the treatment of tumors expressing MAGE, which include lung, pancreatic, gastric, and breast cancers, among others.

Atara Bio Receives FDA Orphan Drug Designation for STM 434, Atara Bio's Activin Inhibitor for Ovarian Cancer

10/20/2015 11:03 am

(CNN Money) Oct 20, 2015 - Atara Biotherapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) granted orphan drug designation for the Company's activin inhibitor, STM 434, for ovarian cancer.

Image-Guided Intensity Modulated Radiation Therapy (Ig-Imrt) Reduces Bowel Side Effects In Cervical Cancer Patients

10/20/2015 11:02 am

(ASTRO) Oct 19, 2015 - For cervical cancer patients undergoing postsurgical radiation therapy, image-guided intensity-modulated radiation therapy (IG-IMRT) resulted in a 14 percent reduction in moderate-to-severe bowel side effects when compared to conventional three-dimensional conformal radiation therapy (3-D CRT), according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 57th Annual Meeting.

Frequent Post-Treatment Follow-Up By Advance Practice Nurses Improves Care For High-Risk Head And Neck Cancer Patients

10/20/2015 11:02 am

(ASTRO) Oct 19, 2015 - For high-risk patients who receive chemoradiation therapy for head and neck cancer, frequent follow-up appointments conducted by advance practice nurses (APN) in a clinical outpatient setting allowed for more intensive symptom management, resulting in fewer post-treatment emergency room visits and hospital admissions compared to historical outcomes, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 57th Annual Meeting.

Do Men's Health Supplements Help Prostate Cancer Patients?

10/20/2015 11:02 am

(CBS News/HealthDay News) Oct 19, 2015 - A new study finds no evidence that men's health supplements help prostate cancer patients.

Aggressive Approach to Anaplastic Thyroid Cancer Shows Benefit

10/20/2015 11:02 am

(Medscape Medical News) Oct 20, 2015 - Survival rates of the rare anaplastic thyroid carcinoma, which has a very poor prognosis, show significant improvement when patients are treated with an aggressive combined-modality therapy, although the toxicities associated with such therapies can take their toll, according to research describing experience with the approach at the Mayo Clinic, in Rochester, Minnesota.

IVF Women Third More Likely To Develop Ovarian Cancer

10/20/2015 11:02 am

(The Telegraph [UK]) Oct 20, 2015 - British health experts said the new findings were serious enough to consider screening IVF patients at regular intervals.

San Diego Scientists Discover How To Pit Leukemia Cells Against Each Other

10/20/2015 11:02 am

(KPBS/City News Service [San Diego, CA]) Oct 19, 2015 - The Scripps Research Institute in La Jolla announced today a discovery of antibodies that can turn leukemia cells against each other, a development that could lead to new cancer therapies.

The Connection Between Cancer Treatment and Cardiac Problems

10/20/2015 11:02 am

(U.S. News & World Report) Oct 20, 2015 - As more people survive cancer, doctors are discovering the long-term side-effects of their treatments.

Cold Genesys Announces FDA Acceptance of a Phase I/II Clinical Trial Using CG0070 Plus an Anti-CTLA-4 Checkpoint Inhibitor as a Neo-Adjuvant Immunotherapy for Muscle Invasive Bladder Cancer

10/20/2015 11:02 am

(Yahoo! Finance) Oct 20, 2015 - Cold Genesys, Inc., a late-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration (FDA) accepted a Phase I/II Clinical Trial (NAOMI) using CG0070 plus an anti-CTLA-4 checkpoint inhibitor as a neo-adjuvant immunotherapy for muscle invasive bladder cancer, or MIBC.

Call for Nominations: 2016 ASCO Election

6/9/2015 12:01 pm

(ASCO in Action) June 8, 2015 - Do you know someone who would make a good ASCO President, Board or Nominating Committee member? If so, please consider nominating that person for the 2016 ASCO Election. Self-nominations are welcome.

Merck’s Pivotal KEYNOTE-006 Study in First-Line Treatment for Advanced Melanoma Met Co-Primary Endpoints and Will be Stopped Early

3/24/2015 09:01 am

(Merck) Mar 24, 2015 - KEYTRUDA demonstrated superior overall survival and progression-free survival compared to ipilimumab.

Affymetrix Announces Recipients of Its 2014 Tumor Profiling Grant Award to Support Translational Cancer Research

6/18/2014 06:03 am

(Affymetrix) June 18, 2014 - Affymetrix announces the three recipients who have been awarded its 2014 Affymetrix Tumor Profiling Grant.

Resistance Is Futile

11/6/2013 12:00 pm

(MIT News) Oct 31, 2013 - A new study from MIT and the University of Toronto offers a possible way to overcome resistance to a chemotherapy drug given to more than half of all cancer patients.

Hospitals Prescribe Big Data to Track Doctors at Work

7/12/2013 10:02 am

(Wall Street Journal) July 11, 2013 - Hospitals around the U.S. are trying to change how doctors practice by using data to monitor their progress toward goals.

Blood Test May Detect Colon Cancer, Early Research Suggests

6/7/2013 10:00 am

(NBC News Vitals blog) June 7, 2013 - New research indicates many people may one day be able to avoid the uncomfortable procedure with a simple, noninvasive and reliable test for colon cancer.

GlobeImmune Initiates Phase 2 Study of a Novel T Cell Stimulating Cancer Vaccine (GI-6207) Targeting CEA in Patients with Metastatic Medullary Thyroid Cancer

4/3/2013 11:05 am

(Reuters) Apr 3, 2013 - GlobeImmune, Inc., announced today the initiation of a Phase 2 clinical trial at the National Cancer Institute (NCI) to evaluate GI-6207 in subjects with medullary thyroid cancer (MTC).